V5 Ultimate
Ultimate
PricingResourcesCompany
English (original)العربيةDeutschΕλληνικάEspañolFrançaisItalianoעברית日本語한국어NederlandsPolskiPortuguêsSvenska
Talk to us Log in Start free trial
Food & Beverage
  • Bakery & Confectionery
  • Food Processing
  • Ingredients & Dry Mixes
  • Sausage & Meat Products
  • Produce Packing
  • Pet Food & Pet Supplements
  • Dairy & Chilled Foods
  • Beverages & Liquid Manufacturing
  • Infant Formula
Pharma & Life Sciences
  • Radiopharmaceuticals
  • Pharmaceutical
  • Medical Devices
  • Veterinary Pharmaceuticals
  • Blood & Tissue
  • Diagnostics & IVD Kits
  • Reference Materials & Standards
  • OTC Topical Creams & Gels
Supplements & Personal Care
  • Dietary Supplements
  • Cosmetics & Personal Care
  • Cannabis & Hemp Manufacturing
  • Fragrances & Perfumery
  • Soaps & Personal Hygiene
  • Botanical Extracts & Essential Oils
Chemicals & Materials
  • Plastics & Resins
  • Agricultural Chemicals
  • Specialty & Industrial Chemicals
  • Printing Inks, Pigments & Construction Chemicals
  • Lubricants & Metalworking Fluids
  • Coatings, Adhesives & Sealants
Other Manufacturing
  • Consumer Products
  • Electronics & Electrical Assembly
  • Textiles & Nonwoven
  • Contract Manufacturing & Co-Packing
  • Packaging & Food-Contact Materials
  • Regulated Warehousing & Distribution
Explore all industries
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Why V5? Product & Features
Why V5?Product & Features
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Explore all industries
    • Bakery & Confectionery
    • Food Processing
    • Ingredients & Dry Mixes
    • Sausage & Meat Products
    • Produce Packing
    • Pet Food & Pet Supplements
    • Dairy & Chilled Foods
    • Beverages & Liquid Manufacturing
    • Infant Formula
    • Radiopharmaceuticals
    • Pharmaceutical
    • Medical Devices
    • Veterinary Pharmaceuticals
    • Blood & Tissue
    • Diagnostics & IVD Kits
    • Reference Materials & Standards
    • OTC Topical Creams & Gels
    • Dietary Supplements
    • Cosmetics & Personal Care
    • Cannabis & Hemp Manufacturing
    • Fragrances & Perfumery
    • Soaps & Personal Hygiene
    • Botanical Extracts & Essential Oils
    • Plastics & Resins
    • Agricultural Chemicals
    • Specialty & Industrial Chemicals
    • Printing Inks, Pigments & Construction Chemicals
    • Lubricants & Metalworking Fluids
    • Coatings, Adhesives & Sealants
    • Consumer Products
    • Electronics & Electrical Assembly
    • Textiles & Nonwoven
    • Contract Manufacturing & Co-Packing
    • Packaging & Food-Contact Materials
    • Regulated Warehousing & Distribution
PricingResourcesCompany
Start free trial Log in Talk to us
HomeGlossaryProduct Complaints (21 CFR 111.553)
Records · The complete guide

Product complaints (21 CFR 111.553)

In short

What qualifies as a dietary supplement quality complaint, when investigation is required, and how complaint records differ from adverse-event reporting records.

2,433 words · ~12 min read
Customer examining a supplement bottle beside a laptop and notebook
Part 111 requires qualified review of all product complaints and investigation of complaints involving a possible specification or other Part 111 failure.
On this page
  1. 01What are product complaints under Part 111?
  2. 02Review every product complaint; investigate possible failures
  3. 03What does an investigation need to cover?
  4. 04What must the complaint record contain?
  5. 05A quality complaint and an adverse event are different assessments
  6. 06Who reports serious adverse events, and when?
  7. 07Retention, electronic records, and inspection access
  8. 08A fictional exercise: count complaints without inventing conclusions
On this page · 8 sections
  1. 1What are product complaints under Part 111?
  2. 2Review every product complaint; investigate possible failures
  3. 3What does an investigation need to cover?
  4. 4What must the complaint record contain?
  5. 5A quality complaint and an adverse event are different assessments
  6. 6Who reports serious adverse events, and when?
  7. 7Retention, electronic records, and inspection access
  8. 8A fictional exercise: count complaints without inventing conclusions
AI · Explain it for MY operation

How does Product Complaints (21 CFR 111.553) apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01What are product complaints under Part 111?

Product complaints are communications alleging a dietary supplement quality concern that could relate to current good manufacturing practice, or cGMP. Under 21 CFR 111.3, the communication can be written, electronic, or oral. The definition covers an allegation—not just a defect already confirmed by testing. Examples in the regulation include foul odor, off taste, foreign material, improper packaging, mislabeling, and illness or injury.

Section 111.553 supplies the written-procedure requirement: firms must establish and follow procedures fulfilling Subpart O. The surrounding provisions supply the substance: §111.560 addresses review and investigation, while §111.570 addresses complaint records. Reading §111.553 alone therefore does not explain the complete complaint-handling obligation.

A price-only inquiry with no quality allegation does not meet this definition merely because a customer is dissatisfied. By contrast, a refund request describing an unusual chemical taste can contain a product complaint. The distinction is the content of the communication, not whether it arrived through customer service or was labeled a complaint.

As a practical intake habit, preserve the reporter’s description before assigning categories. Separate what the reporter observed from what the firm later concludes. A report of a loose seal, for example, is an allegation to assess—not proof of a particular packaging failure.

Three different kinds of statements

This definition distinguishes binding requirements in the regulation and statute, FDA’s nonbinding 2013 adverse-event guidance, and suggested operating practices. Practical examples are not additional legal requirements.

02Review every product complaint; investigate possible failures

Law: Under §111.560(a), a qualified person must review all product complaints to determine whether they involve a possible failure to meet any dietary supplement specification or another Part 111 requirement. A qualified person must investigate any product complaint involving such a possible failure. The trigger is not limited to proven defects or complaints involving illness or injury.

Quality control personnel must review and approve decisions about whether to investigate, along with the findings and followup action of any investigation performed. Both §111.560(b) and §111.135 state this oversight requirement. A decision not to investigate is therefore also subject to QC review and approval.

Section 111.3 defines quality control personnel as designated persons or groups within or outside the organization. These provisions do not require a department with a particular name or establish an additional organizational-independence mandate. What matters here is the designated responsibility and performance of the required reviews.

The Quality-Complaint Decision Path
  1. 1
    Product Complaint ReceivedIdentify a quality allegation that could relate to cGMP.
    • Definition: §111.3
  2. 2
    Qualified-Person ReviewReview every product complaint for a possible specification or other Part 111 failure.
    • Review: §111.560(a)(1)
  3. 3
    Investigation DecisionInvestigate when the possible-failure trigger is met. QC reviews and approves whether to investigate.
    • Investigation: §111.560(a)(2)
    • QC decision review: §111.560(b)
  4. 4
    Findings and FollowupQC reviews and approves investigation findings and followup action. Document required work when performed.
    • QC oversight: §111.560(b)
    • Documentation: §111.570(b)(2)(i)
Read in order. QC oversight applies to the investigation decision and to investigation findings and followup; the relevant-batch and record requirement spans the reviews and investigation.

Practice: Explain the decision using the allegation, relevant specifications, and available evidence. A refund resolves a commercial transaction; it does not substitute for the required technical assessment. Internal review targets can help manage work, but they should not be confused with the separate statutory adverse-event reporting deadlines.

03What does an investigation need to cover?

Law: Section 111.560(c) requires the qualified person’s review and investigation, and the specified QC reviews, to extend to all relevant batches and records. The scope is not automatically confined to the bottle identified by the complainant, but neither does the provision say that every unrelated batch must be investigated.

Practice: Establish relevance by asking what the batches share. For a seal allegation, possible connections include a packaging-material lot, equipment setup, packaging period, or handling route. For a composition allegation, relevant connections might include a component lot, manufacturing records, or related laboratory results. These are investigative questions, not predetermined explanations.

  • Identify the records that can test the allegation, such as batch records, packaging checks, deviations, laboratory data, photographs, or returned material.
  • Explain why other batches are included or excluded using known relationships rather than an arbitrary date range.
  • Distinguish observations, hypotheses, confirmed findings, and unresolved questions in the conclusion.
  • Treat a satisfactory reserve sample as one piece of evidence, not as automatic proof that the allegation was unfounded.

A missing lot number does not remove the requirement to review a product complaint. As practice, seek identifying information such as a label photograph or purchase details and record the limits of any batch association. Do not invent a lot assignment to make the file appear complete.

For a deeper explanation of the manufacturing evidence that may support this work, see the dietary supplement master and batch records guide.

04What must the complaint record contain?

Law: Section 111.570 requires written procedures and a written record of every product complaint related to good manufacturing practice. The person performing a Subpart O requirement must document, at the time of performance, that it was performed. This includes documenting the required review work rather than reconstructing it only when the file closes.

The qualifiers in §111.570 matter. Missing information should remain visibly missing; the regulation does not call for invented details. The middle column below summarizes the required content, while the final column offers practical record-design suggestions.

Record elementRequirement under §111.570(b)(2)(ii)Practical way to make it useful
Product identificationName and description of the dietary supplement.Use enough detail to distinguish the product and presentation.
Batch identificationBatch, lot, or control number, if available.Mark an unavailable number as unavailable; preserve any later confirmation.
Receipt and complainantDate received and the complainant’s name, address, or telephone number, if available.Keep the original receipt information separate from later contacts.
Allegation and useNature of the complaint, including how the product was used, if known.Distinguish the reporter’s account from the investigator’s interpretation.
ResponseReply to the complainant, if any.Retain the actual response or a faithful record of the conversation.
Investigation outcomeFindings and followup action taken when an investigation is performed.Connect conclusions to the evidence and identify unresolved limitations.

Practice: Link the complaint, supporting evidence, investigation decision, and QC review so another reader can follow the reasoning. Preserve follow-up communications even when they concern an existing complaint; avoiding duplicate counts is different from deleting relevant information.

05A quality complaint and an adverse event are different assessments

A Part 111 product complaint concerns quality that could relate to cGMP. Separately, 21 U.S.C. 379aa-1 defines an adverse event as an adverse health-related event associated with use of a dietary supplement. One communication can raise both questions, but neither category automatically establishes the other.

Law: A serious adverse event is an adverse event resulting in death, a life-threatening experience, inpatient hospitalization, persistent or significant disability or incapacity, or a congenital anomaly or birth defect. It also includes an event requiring, based on reasonable medical judgment, medical or surgical intervention to prevent one of those outcomes.

An emergency-room visit alone is not a listed seriousness criterion. It may nevertheless involve a life-threatening experience or a qualifying intervention. For intake, ask what outcome or treatment occurred rather than treating the location of care as the answer.

One communication, two distinct assessments

Shared Communication

Preserve what was reported and when it was received.

  • Practice: retain the original account

Quality Assessment

Does the allegation concern quality that could relate to cGMP? Does review identify a possible Part 111 failure?

  • Law: §§111.3 and 111.560

Adverse-Event Assessment

Is there an adverse health-related event associated with use? Does it meet a statutory seriousness criterion?

  • Law: 21 U.S.C. 379aa-1(a)

Distinct Records and Decisions

Link related evidence without merging the legal tests or retention duties.

  • Practice: preserve separate assessment outcomes
The same intake can support either assessment or both. Keep the quality conclusion and health-event assessment separately identifiable; neither depends on proving causation first.

The reporting statute uses association with the supplement, not a prerequisite that the firm prove causation. It also expressly says submission is not an admission that the supplement caused or contributed to the event. As practice, keep the reporting assessment moving alongside the quality investigation rather than waiting for a final causal explanation.

06Who reports serious adverse events, and when?

Law: Under 21 U.S.C. 379aa-1(b)(1), the responsible person is the manufacturer, packer, or distributor whose name appears on the label of a dietary supplement marketed in the United States. That person must submit reports received of serious adverse events associated with the supplement when used in the United States, accompanied by a copy of the label on or within the retail packaging. The statute requires use of the MedWatch form.

The statute’s 15-business-day deadline applies to serious adverse event reports received through the address or phone number on the label. The broader reporting obligation is not confined to those channels. FDA’s nonbinding 2013 guidance, Question 10, recommends the same 15-business-day timeframe for reports received by other means.

The statute separately requires submission of new medical information related to a submitted serious adverse event report when the responsible person receives that information within one year of the initial report. Submission is due no later than 15 business days after receiving the new information.

FDA guidance also addresses incomplete intake. Question 10 describes the reporting clock as beginning when the five minimum data elements are known: an identifiable patient, an initial reporter, the responsible person’s identity and contact information, the suspect supplement, and a serious adverse event. That is guidance on applying the reporting framework, not permission to wait for proof of causation.

For operational detail on intake, incomplete information, submissions, and followup, use the supplement adverse-event reporting readiness guide. This definition explains the boundary between the duties rather than serving as a reporting calculator or submission checklist.

07Retention, electronic records, and inspection access

The Part 111 retention rule and the adverse-event statute cover different records. Do not compress them into a general statement that complaint records last one or two years, or that only FDA-filed serious events require six-year retention.

Record categoryBinding retention requirementImportant distinction
Part 111-required records when shelf life dating is usedKeep for one year past the shelf life date under §111.605(a).This is one branch of the rule, not a whichever-is-longer comparison.
Part 111-required records when shelf life dating is not usedKeep for two years beyond distribution of the last batch associated with the records under §111.605(a).Use the associated last batch, not simply the complaint receipt date.
Records related to adverse-event reports received by the responsible personMaintain for six years under 21 U.S.C. 379aa-1(e)(1).Covers each adverse-event report, serious or nonserious, whether or not submitted to FDA.

Law: Section 111.605(b) permits original records, true copies, or electronic records. For Part 111-required electronic records, §111.605(c) states: “All electronic records must comply with part 11 of this chapter.” The scope is the required records—not every software system used anywhere in the business.

Separately, FDA’s nonbinding 2013 guidance, Question 25(c), states that electronic records created and maintained to satisfy the adverse-event recordkeeping requirement are subject to Part 11. This is not a blanket assurance about any software. As practice, identify which required records are maintained electronically before evaluating their controls.

The adverse-event statute also requires the responsible person to permit an authorized person access to required adverse-event records during a statutory inspection. As practice, keep related records retrievable, and track both retention obligations when the same evidence supports a quality complaint and an adverse-event file.

08A fictional exercise: count complaints without inventing conclusions

Practice exercise—entirely fictional: A firm receives 18 contacts during a review period. Four are follow-up messages about complaints already counted. Five separate contacts concern price only, with no quality or health allegation. The remaining nine contacts are nine distinct quality complaints. Assume these groups do not overlap.

The reconciliation is 18 − 4 − 5 = 9 distinct quality complaints. Suppose six concern seal appearance and three concern tablet appearance: 6 + 3 = 9. Seal-related complaints represent 6 ÷ 9 × 100 = 66.7% of those nine complaints, rounded to one decimal place.

That percentage describes the fictional complaint mix—not a defect rate among products sold, an injury rate, or evidence of a packaging cause. The four follow-up messages remain part of the relevant records even though they are not counted as four additional complaints. No count or percentage replaces the §111.560 possible-failure assessment.

Arithmetic is not a safety or reporting decision

This exercise is not an actual reporting calculator. It establishes no threshold for investigation, causation, seriousness, FDA reporting, or product safety.

For practical pattern review, define the counting unit, retain the underlying narratives, and state the period and categories used. Repeated allegations can guide questions for further review; they do not by themselves prove a shared cause. Where packaging evidence is relevant, the supplement packaging and labeling controls guide provides related context.

Frequently asked questions

Q.Does a product complaint have to be written?+

No. Section 111.3 includes written, electronic, and oral communications. Section 111.570 requires a written record of every product complaint related to good manufacturing practice, so an oral allegation can lead to a required written complaint record.

Q.Is investigation required only when someone becomes ill?+

No. Under §111.560(a), the trigger is a possible failure to meet any specification or another Part 111 requirement. Illness or injury is not a prerequisite, and the qualified person must review all product complaints.

Q.What if the complainant cannot provide a lot number?+

The complaint still requires review. Section 111.570 qualifies the lot-number field with “if available.” As practice, seek additional identifying information and document uncertainty rather than assigning an unsupported lot number.

Q.Can quality control personnel be outside the organization?+

Yes. Section 111.3 allows designated quality control persons or groups within or outside the organization. The required QC review and approval of investigation decisions, findings, and followup still apply.

Q.Is Part 111 retention based on whichever period is longer?+

No. Section 111.605(a) uses alternative rules: one year past the shelf life date if shelf life dating is used, or two years beyond distribution of the last associated batch. Separately, the responsible person must retain records related to each adverse-event report received for six years, including nonserious reports.

Q.Does reporting a serious adverse event mean the supplement caused it?+

No. The statute requires reporting based on the specified association and seriousness conditions, without first requiring proof of causation. It expressly states that submission is not an admission that the supplement caused or contributed to the event.

Primary sources

  • 21 CFR Part 111 — definitions, QC oversight, Subpart O, and §111.605
  • 21 U.S.C. 379aa-1 — serious adverse-event reporting and records
  • FDA — September 2013 nonbinding guidance on dietary supplement adverse-event reporting and recordkeeping

Further reading

  • Supplement Adverse-Event Reporting Readiness
    Operational detail for the separate adverse-event intake, reporting, and followup assessment.
  • Dietary Supplement Master and Batch Records
    Understand the manufacturing evidence that can support a complaint investigation.
  • Supplement Packaging and Labeling Controls
    Explore records and controls relevant to packaging and labeling allegations.
Software that covers Product Complaints (21 CFR 111.553)
V5 Ultimate (Dietary Supplements)
V5 Ultimate runs Master Manufacturing Records and executed Batch Production Records under 21 CFR Part 111, with mandatory…
V5 Ultimate cGMP Software
Batch records, investigations, calibration and training organised around 21 CFR 210/211, with Part 11 audit trails and people…
V5 Ultimate Dietary Supplements
Written for supplement contract manufacturers and brand owners tired of surviving FDA 483s on paper.
Talk to us about Product Complaints (21 CFR 111.553)

Want to see how Product Complaints (21 CFR 111.553) could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Inside V5
  • → QMS — quality records next to the work they concern.
  • → Document control — one version in force, every change signed and explained.
  • → Score your compliance gap — then download the validation pack.
  • → Audits whose findings reach an owner.
Example reports
V5Ultimate

Sample report

CAPA Record

Quality system

CAPA RecordView on screen or print
V5Ultimate

Sample report

Complaint File

Quality system

Complaint FileView on screen or print
→ All example reports
Regulatory anchors
  • 21 CFR 111.553
  • 21 CFR 111.560
Related terms
  • → Supplement Adverse Event Reporting

Next Step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse All Features

Showing the site for the United States. Local spelling, dates and prices are applied automatically; change the language at the top of the page.

V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal Centre

© S.G. Systems, LLC